China is making significant strides in the industrial development of brain-machine interface technology, with the unveiling of the NeuCyber Array BMI System at the 2024 Zhongguancun Forum in Beijing. This system, developed by Chinese scientists, marks a milestone in high-performance invasive BMI technology in the country.
The application of brain-machine interface technology was demonstrated through a monkey controlling a robotic arm with implanted electrode filaments in its brain, showcasing the potential for thought-controlled actions.
Experts at the forum highlighted the role of BMI technology in driving a new wave of scientific and technological revolution, with China emerging as a key player in innovation and a growing market for BMI technology. The country has seen a rapid increase in BMI scientific research projects, with a significant portion of global patent applications related to BMI originating from China.
While BMI technology is currently predominantly used in the medical field for conditions such as epilepsy, Parkinson’s disease, and depression, experts believe that there is immense potential for its application in a wide range of neurological disorders.
The growth of BMI technology in China is fueled by innovation, clinical resources, and the increasing demand for brain disease treatment. Professor Hong Bo from Tsinghua University emphasized the need for strategic development to capitalize on the opportunities presented by the expanding BMI industry.
